Analysis of PBMC from chronic hepatitis B and HBV-associated hepatocellular carcinoma patients suggest that TLR9 mRNA levels are downregulated in CHB and that TLR9 protein is drastically reduced in both CHB and HCC patients. Here, TLR9 is linked to hepatocellular carcinoma.